HOME >> MEDICINE >> NEWS
Smoking increases risk for liver, pancreatic and colorectal cancers

CHICAGO, IL (May 17, 2005) Smoking may have a devastating effect on gastrointestinal health and increase a person's risk of developing pancreatic and liver cancer, according to new research presented today at Digestive Disease Week 2005 (DDW). Furthermore, data from the Nurses' Health Study shows that meat intake and smoking play a part in significantly increasing a woman's risk of colorectal cancer. DDW is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.

"The effects of smoking on the respiratory system are well known and well documented through research," said Lee Kaplan, M.D., Ph.D., of Massachusetts General Hospital. "Recognizing that this high-risk behavior also hurts the digestive system is fundamental in preventing life-threatening cancers and improving overall health."

Smoking and Alcohol Use Associated with Markedly Earlier Age of Onset in Pancreatic Adenocarcinoma (Abstract 360)

With the link between smoking and pancreatic adenocarcinoma established, researchers from Evanston Northwestern Healthcare, an academic health system affiliated with Northwestern University, investigated the impact of smoking and alcohol use on the age of pancreatic cancer diagnosis and found that both play significant roles in the early onset of the disease.

Patients who were currently alcohol and tobacco users were diagnosed an average of 13 years earlier than individuals who had never used alcohol or tobacco, at median ages of 61 and 74 respectively for initial diagnosis. The data shows that smoking may have a more profound negative effect on the pancreas than alcohol, with current tobacco users being consistently diagnosed earlier than individuals who were current or former alcohol users. Study results also indicate that smoking and alcohol use may have a long-term effect on the pancreas, even after cessation. Indivi
'"/>


17-May-2005


Page: 1 2 3 4

Related medicine news :

1. Smoking may strongly increase long-term risk of eye disease
2. Smoking may interfere with alcoholics neurocognitive recovery during abstinence
3. Smoking rate has plummeted in New York City
4. Smoking and sleep top the list of lifestyle factors impacting oral health
5. Smoking, growing private hospital care for poor and US flu vaccine policies
6. Smoking influences Crohns disease
7. Smoking ban dramatically reduces air pollution in Irish pubs
8. Smoking may be a risk factor for tuberculosis
9. Smoking increases risk of TB infection, says new study
10. Smoking worsens knee osteoarthritis
11. Smoking cessation therapy may be harmful for ICU patients

Post Your Comments:
(Date:4/23/2014)... of endogenous neural precursor cells cannot alone compensate ... the perspective of neural plasticity, Dr. Yun Xiang ... observed the effects of functional electrical stimulation treatment ... of basic fibroblast growth factor and epidermal growth ... side. The researchers found that functional electrical stimulation ...
(Date:4/22/2014)... (Chicago) A recently FDA-approved device has been shown ... as much as 50 percent. When coupled with an ... Rush, the device facilitated the complete elimination of seizures ... in the decade-long clinical trials. , That,s good news ... in the U.S. living with epilepsy whose seizures can,t ...
(Date:4/22/2014)... all lung cancers are small cell lung cancers ... to chemotherapy. However, researchers at Virginia Commonwealth University ... the mechanisms leading to this resistance that may ... primarily by mediating B-cell lymphoma 2 (Bcl-2) family ... Depending on their function, this family of proteins ...
(Date:4/22/2014)... Hopkins scientists have found a way to block abnormal ... of atherosclerosis, the main cause of heart attacks and ... The condition develops when fat builds inside blood vessels ... greatly reducing their ability to feed oxygen-rich blood to ... series of experiments, described April 7 in the journal ...
(Date:4/22/2014)... massive health care spending, a new RAND study concludes ... incentivize pharmaceutical companies and device makers to develop products ... medical technologies and their use, a new study suggests ... medical devices get created in the first place. The ... as little loss of health as possible and to ...
Breaking Medicine News(10 mins):Health News:Newly approved brain stimulator offers hope for individuals with uncontrolled epilepsy 2Health News:Scientists pinpoint protein that could improve small cell lung cancer therapies 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 3Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 4Health News:US medical innovation needs smarter incentives to cut health spending, study finds 2Health News:US medical innovation needs smarter incentives to cut health spending, study finds 3
(Date:1/15/2014)... PHILADELPHIA , Jan. 15, 2014  Echo Therapeutics, Inc. ... company developing its Symphony® CGM System as a non-invasive, ... Robert F. Doman , Executive Chairman and Interim CEO ... Capital Markets, Tenth Annual Equity Conference. ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... and Market Analysis to 2022 ... Dermatitis - India Drug Forecast and Market ...
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
Cached News: